Helping Clients Close the Right Deals—The Right Way

In FDA-regulated industries, commercial contracts are rarely straightforward. Business decisions are often tied to regulatory frameworks—whether it’s ensuring product quality, protecting patient data, or avoiding pitfalls under the Anti-Kickback Statute.

That’s where Gardner Law comes in.

From startups to global manufacturers, our team has supported clients through the full lifecycle of commercial agreements. Our role often starts well before a deal is inked—helping clients assess risks, structure transactions, and align terms with applicable law.

We assist with:

• Commercial diligence and deal structuring
• Supply chain, manufacturing, and quality agreements
• Licensing, commercialization, and distribution
• Clinical trial and research agreements
• M&A, divestitures, and strategic partnerships
• Technology, data, and privacy contracts
• Core commercial contracts (MSA, SOW, product sale, NDAs, consulting agreements)

Our team of attorneys comprises former in-house counsel, business attorneys, regulatory advisors and engineers who understand how to drive business forward while managing legal and compliance risk.

“For companies operating in regulated industries, commercial transactions are never just about the business terms—they're about navigating risk, protecting innovation, and aligning with a complex web of regulatory requirements. Our team brings decades of real-world experience to the table, helping clients structure deals that are not only strategic, but defensible.”
— Mark Gardner, Founding Attorney, Gardner Law

Whether you're negotiating your first clinical trial agreement or acquiring a product portfolio, we help ensure your legal strategy keeps pace with your business goals.